Introduction

Hepatitis B virus (HBV) serology is often considered difficult because multiple antigens, antibodies and molecular markers appear and disappear at different stages of infection.

The key to interpretation is not to interpret one marker in isolation.

Instead, interpret the complete pattern using:

• HBsAg

• anti-HBs

• total anti-HBc

• IgM anti-HBc

• HBeAg

• anti-HBe

• HBV DNA

• ALT

• clinical history

• previous vaccination/infection history

• duration of HBsAg positivity

The central diagnostic questions are:

1. Is the patient infected now?

2. Is the infection acute or chronic?

3. Has the patient recovered?

4. Is the patient immune because of vaccination?

5. Is there occult HBV infection?

6. Is there active viral replication?

1. The Core HBV Serology Framework

Before interpreting complicated patterns, memorize five markers:

Then add:

2. The First Question: Is HBsAg Positive?

This should usually be the starting point.

HBsAg positive

Think:

Then determine:

acute vs chronic

using:

• IgM anti-HBc

• previous results

• duration of HBsAg positivity

• clinical context

• HBV DNA

• ALT

3. HBsAg Negative

If HBsAg is negative, ask:

Is anti-HBs positive?

and

Is anti-HBc positive?

This immediately separates:

• vaccinated individuals

• recovered individuals

• susceptible individuals

• isolated anti-HBc patterns

4. The Master Algorithm

                    HBV SERLOGY
                         ↓
                    HBsAg?
                 ┌───────┴───────┐
                 ↓               ↓
               POSITIVE        NEGATIVE
                 ↓               ↓
          Current infection   Anti-HBs?
                 ↓          ┌─────┴─────┐
        IgM anti-HBc?       ↓           ↓
          ┌────┴────┐     POSITIVE    NEGATIVE
          ↓         ↓        ↓           ↓
        POSITIVE  NEGATIVE  Anti-HBc?  Anti-HBc?
          ↓         ↓       ┌──┴──┐     ┌──┴──┐
       ACUTE      CHRONIC    +     −     +     −
                             ↓     ↓     ↓     ↓
                          RESOLVED VACC. ISOLATED SUSCEPTIBLE

This is the basic framework.

5. Pattern 1 — Susceptible Individual

Results

Interpretation

Susceptible to HBV infection

There is no serological evidence of:

• current infection

• previous natural infection

• vaccination-induced immunity

Next step

The person should be evaluated for HBV vaccination according to current recommendations.

6. Pattern 2 — Vaccine-Induced Immunity

Results

Interpretation

Immune due to vaccination

Why is anti-HBc negative?

Because HBV vaccination contains:

HBsAg

but does not expose the individual to:

Whole HBV

Therefore, vaccination induces:

anti-HBs

but not:

anti-HBc

7. Pattern 3 — Resolved Natural HBV Infection

Results

Interpretation

Resolved natural HBV infection

The patient was previously infected and subsequently cleared detectable HBsAg.

The anti-HBc remains as evidence of previous natural infection.

8. Pattern 4 — Acute HBV Infection

Typical results

Interpretation

Acute/recent HBV infection

The most important marker supporting acute infection is:

IgM anti-HBc

9. Why IgM Anti-HBc Is So Important

HBsAg positivity alone cannot distinguish:

acute HBV infection

from

chronic HBV infection

because both may have:

HBsAg positive

The presence of IgM anti-HBc strongly supports recent infection.

However, IgM anti-HBc may also become positive during severe exacerbations of chronic HBV.

Therefore:

10. Pattern 5 — Chronic HBV Infection

Typical pattern

The defining feature is:

HBsAg persistence ≥6 months

Therefore:

11. HBeAg-Positive Chronic Infection

Typical pattern:

This generally represents a phase with:

• active viral replication

• high HBV DNA

• high infectiousness

But liver inflammation can vary.

12. HBeAg-Negative Chronic Infection

Typical pattern:

The critical point is:

The patient may have:

HBeAg-negative chronic hepatitis

with:

• elevated ALT

• significant HBV DNA

• progressive liver disease

Precore and basal core promoter variants are important in this setting.

13. Pattern 6 — Window Period

The HBV window period occurs during recovery from acute infection.

HBsAg has disappeared

but

anti-HBs has not yet appeared.

Typical pattern:

Most important marker

IgM anti-HBc

This is the classic exam pattern:

14. Why the Window Period Matters

If only HBsAg and anti-HBs are tested during the window period:

• HBsAg = negative

• anti-HBs = negative

The patient may appear uninfected.

But:

IgM anti-HBc

reveals recent HBV infection.

Therefore, anti-HBc testing is crucial when recent HBV infection is suspected.

15. Pattern 7 — Isolated Anti-HBc

Results

This is called:

Isolated anti-HBc positivity

This pattern has several possible explanations.

16. Causes of Isolated Anti-HBc

Possibility 1 — Remote resolved infection

The patient previously had HBV infection.

Anti-HBs has subsequently declined below detectable levels.

Possibility 2 — Window period

The patient has acute HBV infection but has not yet developed detectable anti-HBs.

Look for:

IgM anti-HBc positivity

Possibility 3 — Occult HBV infection

HBV DNA may be detectable despite HBsAg negativity.

Possibility 4 — False-positive anti-HBc

This becomes particularly relevant when the pre-test probability of HBV infection is low.

Possibility 5 — Low-level persistent infection

Rarely, low-level HBV infection may produce this pattern.

17. Approach to Isolated Anti-HBc

A practical approach is:

Isolated anti-HBc
       ↓
Check clinical history
       ↓
Previous HBV infection?
Vaccination?
Risk factors?
       ↓
Check IgM anti-HBc if acute infection suspected
       ↓
Consider HBV DNA
       ↓
Consider repeat serology
       ↓
Interpret according to clinical context

The exact testing strategy depends on the patient's risk and clinical situation.

18. Pattern 8 — Occult HBV Infection

Occult HBV infection is characterized by:

HBsAg negative

but

HBV DNA detectable

in appropriate specimens.

Serology may show:

• anti-HBc positive

• anti-HBs positive

• anti-HBs negative

• or occasionally absent HBV antibodies

Therefore:

19. Why Occult HBV Matters

It is particularly important in:

• chemotherapy

• biological immunosuppression

• hematopoietic stem-cell transplantation

• solid-organ transplantation

• selected blood donation settings

• unexplained liver disease

Immunosuppression can permit:

HBV reactivation

even after apparent resolution of infection.

20. Pattern 9 — HBsAg Positive + Anti-HBs Positive

This is an unusual pattern.

Possible explanations include:

• coexistence of different viral variants

• immune escape variants

• transitional serological states

• assay-related phenomena

It should not simply be dismissed as a laboratory error.

If clinically relevant, repeat testing and molecular evaluation may be appropriate.

21. Pattern 10 — HBsAg Positive + Anti-HBc Negative

This pattern requires careful consideration.

Possible explanations include:

• very early infection

• false-positive HBsAg

• transient HBsAg positivity following vaccination

• laboratory/assay interference

Important clue

If HBsAg is unexpectedly positive:

repeat/confirm the result using an appropriate confirmatory strategy.

22. Transient HBsAg Positivity After Vaccination

HBsAg can occasionally be transiently detectable shortly after hepatitis B vaccination because the vaccine contains recombinant HBsAg.

Therefore:

Clinical context is essential.

23. Pattern 11 — HBeAg Positive + High HBV DNA

This pattern generally indicates:

Active HBV replication

and usually:

High infectious potential

However, treatment decisions cannot be made from HBeAg alone.

They require integration of:

• HBV DNA

• ALT

• fibrosis

• age

• clinical status

• cirrhosis status

• other risk factors

24. Pattern 12 — HBeAg Negative + High HBV DNA

This is an important diagnostic trap.

The patient can have:

HBeAg-negative chronic hepatitis

despite:

• HBeAg negative

• anti-HBe positive

Possible explanation:

Precore/basal core promoter variants

Therefore:

25. Pattern 13 — HBsAg Positive + HBV DNA Undetectable

This does not necessarily mean:

“No HBV.”

Possible explanations include:

• very low-level replication

• inactive infection

• antiviral suppression

• assay sensitivity limitations

• transient infection

• unusual serological states

Interpret together with:

• ALT

• HBeAg

• fibrosis

• treatment history

• serial HBV DNA measurements

26. Pattern 14 — HBsAg Positive + Normal ALT

This is another common trap.

Normal ALT does not automatically mean:

“No clinically important HBV disease.”

The patient may have:

• low-replicative chronic infection

• early disease

• fluctuating disease

• significant fibrosis despite currently normal ALT

Therefore, liver disease assessment should not rely exclusively on ALT.

27. Pattern 15 — HBsAg Positive + High HBV DNA + Elevated ALT

This pattern strongly suggests:

Active HBV infection with hepatic inflammation

Further evaluation should include:

• fibrosis assessment

• liver imaging where indicated

• HBeAg status

• treatment eligibility

• assessment for cirrhosis

• HCC surveillance according to risk

28. HBeAg Seroconversion

Before

HBeAg +

anti-HBe −

After

HBeAg −

anti-HBe +

This is:

HBeAg seroconversion

It usually indicates a shift toward immune control and reduced viral replication.

However:

HBsAg may remain positive.

HBV DNA may remain detectable.

Chronic hepatitis may still develop.

29. HBsAg Seroclearance

The major favorable serological event is:

HBsAg loss

followed by:

anti-HBs development

This is often termed:

Functional cure

It represents a major therapeutic and natural-history milestone.

However, HBV DNA/cccDNA may persist at very low levels in some individuals, meaning that complete sterilizing eradication is not necessarily achieved.

30. Acute Infection vs Chronic Infection

Most useful distinction

IgM anti-HBc +

supports recent infection.

HBsAg ≥6 months

establishes chronicity.

31. Resolved Infection vs Vaccination

Golden rule

Anti-HBc differentiates natural infection from vaccination.

32. Acute Infection vs Window Period

The window period is essentially a transitional stage of acute infection.

33. HBeAg-Positive vs HBeAg-Negative Disease

34. The Role of HBV DNA

HBV DNA becomes particularly important when serology is ambiguous.

For example:

HBeAg negative + anti-HBe positive

does not tell you whether viral replication is:

• absent

• low

• moderate

• high

HBV DNA answers this question.

35. The Role of ALT

ALT indicates:

Hepatocellular injury

It does not directly measure:

• HBV replication

• infectivity

• fibrosis

• cccDNA

Therefore:

HBV DNA ≠ ALT

A patient can have:

high HBV DNA + normal ALT

or:

low HBV DNA + elevated ALT

for different reasons.

36. Serology Interpretation Matrix

37. A More Complete Clinical Algorithm

START
  ↓
HBsAg
  ↓
┌───────────────────────┐
│                       │
POSITIVE              NEGATIVE
│                       │
↓                       ↓
Current infection     Anti-HBs?
│                    ┌────┴────┐
↓                    │         │
IgM anti-HBc?       +         −
│                   │          │
├── + → Acute       │        Anti-HBc?
│                   │       ┌──┴──┐
└── − → Chronic     │       +     −
                    │       │     │
                 Vaccinated │   Susceptible
                            │
                         Isolated
                         anti-HBc

Then:

If HBsAg positive
        ↓
HBV DNA
        ↓
HBeAg / anti-HBe
        ↓
ALT
        ↓
Fibrosis assessment
        ↓
Determine disease phase
        ↓
Assess treatment eligibility

38. When to Suspect Occult Infection

Think about occult HBV when:

• HBsAg is negative

• anti-HBc is positive

• HBV DNA is detectable

Especially in:

• immunosuppressed patients

• transplant recipients

• patients receiving B-cell-depleting therapy

• patients with unexplained liver disease

• patients with prior HBV exposure

39. HBV Serology in Immunosuppression

This is an area where apparently “resolved” HBV becomes clinically important.

A patient with:

HBsAg −

anti-HBc +

may still have persistent HBV DNA/cccDNA.

Immunosuppression can reduce immune control.

Result:

HBV reactivation

Therefore, anti-HBc screening is important before many immunosuppressive therapies.

40. Important Serological Pitfalls

Pitfall 1

HBsAg negative = no HBV ever

❌ Incorrect.

The patient may have:

• resolved infection

• occult infection

• window-period infection

Pitfall 2

Anti-HBs positive = vaccinated

❌ Not necessarily.

Anti-HBs can result from:

• vaccination

• natural infection followed by recovery

Check anti-HBc.

Pitfall 3

Anti-HBc positive = active infection

❌ Incorrect.

Anti-HBc can persist after resolved infection.

Pitfall 4

HBeAg negative = inactive HBV

❌ Incorrect.

HBeAg-negative chronic hepatitis can have substantial HBV replication.

Pitfall 5

Normal ALT = no significant HBV disease

❌ Incorrect.

Fibrosis and other complications can occur despite normal ALT.

Pitfall 6

Undetectable HBV DNA = eradication

❌ Incorrect.

cccDNA may persist.

41. Exam-Focused Interpretation

Question:

HBsAg positive + IgM anti-HBc positive.

Answer:

Acute HBV infection, assuming the clinical context supports a recent infection.

Question:

HBsAg negative + anti-HBs positive + anti-HBc negative.

Answer:

Vaccination-induced immunity.

Question:

HBsAg negative + anti-HBs positive + anti-HBc positive.

Answer:

Resolved natural HBV infection.

Question:

HBsAg negative + anti-HBs negative + IgM anti-HBc positive.

Answer:

Window period.

Question:

HBsAg positive for >6 months + anti-HBc positive.

Answer:

Chronic HBV infection.

Question:

HBsAg positive + HBeAg negative + high HBV DNA.

Answer:

Consider:

HBeAg-negative chronic hepatitis, often associated with precore/basal core promoter variants.

42. One-Minute HBV Serology Memory Map

             HBsAg
               ↓
       ┌───────┴───────┐
       ↓               ↓
      +                -
       ↓               ↓
 CURRENT INFECTION   Anti-HBs
       ↓          ┌─────┴─────┐
 IgM anti-HBc?    +           -
   ┌───┴───┐      ↓           ↓
   +       -   VACCINE      Anti-HBc
   ↓       ↓              ┌────┴────┐
 ACUTE   CHRONIC           +         -
                           ↓         ↓
                       RESOLVED   SUSCEPTIBLE

43. The Five Golden Rules

Rule 1

HBsAg = current infection

Rule 2

Anti-HBs = immunity

Rule 3

Anti-HBc = natural exposure

Rule 4

IgM anti-HBc = recent infection, but can also occur in chronic flares

Rule 5

HBV DNA = viral replication

If these five rules are firmly understood, most HBV serology questions become straightforward.

44. Final Clinical Perspective

HBV serology should never be interpreted as a collection of isolated positive and negative results.

Instead, it should be viewed as a dynamic timeline of virus-host interaction.

The ideal interpretation integrates:

Serology + HBV DNA + ALT + duration + clinical history + fibrosis assessment

The most important diagnostic distinctions are:

susceptible

↓

vaccinated

↓

acute infection

↓

window period

↓

chronic infection

↓

resolved infection

↓

isolated anti-HBc / occult infection

Once these patterns are recognized, the next step is to determine the patient's HBV disease phase and activity, which requires integration of HBeAg, HBV DNA, ALT and liver fibrosis.

Standard References

1. Knipe DM, Howley PM, editors. Fields Virology. Wolters Kluwer.

2. Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier.

3. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. Elsevier.

4. Carroll KC, et al. Jawetz, Melnick & Adelberg's Medical Microbiology. McGraw-Hill.

5. Ryan KJ, Ray CG. Sherris Medical Microbiology. McGraw-Hill.

6. World Health Organization. Guidelines for the Prevention, Diagnosis, Care and Treatment for People with Chronic Hepatitis B Infection. WHO, 2024.

7. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection. Journal of Hepatology, 2025.

8. Terrault NA, et al. AASLD Guidance on Chronic Hepatitis B.

9. Centers for Disease Control and Prevention. Clinical Testing and Diagnosis for Hepatitis B.

10. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Reviews Immunology.

11. Ganem D, Prince AM. Hepatitis B virus infection—natural history and clinical consequences. New England Journal of Medicine.

12. Locarnini S, et al. Major reviews and consensus literature on HBV virology, serology and antiviral resistance.